ArticleInternational journal of biological sciences2020

Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway.

Jun Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.